PathoQuest offers biopharmaceutical companies a game changing Genomic approach to secure the biosafety of biological drugs like cell & gene therapy products, vaccines and recombinant. It allows to reduce time to market of innovative treatments.

PathoQuest’s technology combines a Next-Generation Sequencing (NGS) platform with  a proprietary sample preparation processes completed by  a proprietary pathogen genome sequence databases and automated analysis pipeline.

For more information about PathoQuest, visit or contact us at